Vi bøger
Trustpilot
Levering: 1 - 2 hverdage
Hjælp
Login
  1. Forside
  2. Bøger
  3. Business og læring
  4. Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents - Bog

- Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988

indgår i Developments in Cardiovascular Medicine serien

Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents
Bag om Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 and 28, 1988

Vis mere
  • Sprog:
  • Engelsk
  • ISBN:
  • 9781461288886
  • Indbinding:
  • Paperback
  • Sideantal:
  • 298
  • Udgivet:
  • 10. Oktober 2011
  • Udgave:
  • 11989
  • Størrelse:
  • 155x235x17 mm.
  • Vægt:
  • 492 g.
  • 8-11 hverdage.
  • 9. Oktober 2024
På lager

Normalpris

Medlemspris

Prøv i 30 dage for 45 kr.
Herefter fra 79 kr./md. Ingen binding.

Beskrivelse af Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 and 28, 1988

Brugerbedømmelser af Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents



Andre købte også..
Find lignende bøger
Bogen Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents findes i følgende kategorier:

Gør som tusindvis af andre bogelskere

Tilmeld dig nyhedsbrevet og få gode tilbud og inspiration til din næste læsning.